Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Non-Suicidal Self-Injury
NCT04005053Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Aug 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in nonsuicidal self-injury (NSSI), sponsored by University of Minnesota. Started Aug 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
nonsuicidal self-injury (NSSI)
Beyond the preview
Go deeper on NCT04005053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04005053.